Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Corplex Donepezil TDS vs Oral Aricept in Healthy Volunteers
NCT04617782Phase 1Completed
- Sponsor
- Corium
- Start
- Dec 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (3 arms), sponsored by Corium. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Dec 2020; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04617782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04617782.